Parvalbumin and calbindin D-28K immunoreactivity in central ganglioglioma and dysplastic gangliocytoma of the cerebellum. Report of two cases.
Calbindin D-28K and parvalbumin immunocytochemistry were used in the study of central ganglionic cell tumors. Most neurons in the ganglioglioma were immunoreactive to calbindin D-28K, but a few cells were labeled with antibodies against parvalbumin. In contrast, most cells in dysplastic gangliocytoma of the cerebellum were parvalbumin immunoreactive, but fewer reacted with anti-calbindin antibodies. These latter cells had two or three dendrites with claw-shaped terminals and axons with recurrent collateral branches and varicose terminals filled with strings and buttons. These observations suggest that central ganglionic cell tumors, including dysplastic gangliocytoma of the cerebellum, are composed of neurons which, on the basis of their calcium-binding protein content, have particular metabolic and electrophysiological properties.
Ferrer
I
I
Unit of Neuropathology, Hospital de Bellvitge Príncipes de España, University of Barcelona, Spain.
Isamat
F
F
López-Obarrio
L
L
Conesa
G
G
Rimbau
J
J
Alcántara
S
S
Español
I
I
Zújar
M J
MJ
D000293:Adolescent; D000328:Adult; D064026:Calbindins; D002528:Cerebellar Neoplasms / Q000737:chemistry*; D005260:Female; D005729:Ganglioneuroma / Q000737:chemistry*; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D009363:Neoplasm Proteins / Q000032:analysis*; D009447:Neuroblastoma / Q000737:chemistry*; D010320:Parvalbumins / Q000032:analysis*; D064030:S100 Calcium Binding Protein G / Q000032:analysis*
D064026:Calbindins; D009363:Neoplasm Proteins; D010320:Parvalbumins; D064030:S100 Calcium Binding Protein G